Marc E. Lippman
About
In The Last Decade
Marc E. Lippman
406 papers receiving 28.8k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Oncology 12.7k
- Molecular Biology 12.5k
- Genetics 10.2k
- Cancer Research 7.0k
- Endocrinology, Diabetes and Metabolism 3.9k
Countries citing papers authored by Marc E. Lippman
This map shows the geographic impact of Marc E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Lippman more than expected).
Fields of papers citing papers by Marc E. Lippman
This network shows the impact of papers produced by Marc E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Lippman. The network helps show where Marc E. Lippman may publish in the future.
Co-authorship network of co-authors of Marc E. Lippman
This figure shows the co-authorship network connecting the top 25 collaborators of Marc E. Lippman. A scholar is included among the top collaborators of Marc E. Lippman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc E. Lippman. Marc E. Lippman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 12 | |
| 6 | 37 | |
| 7 | 9 | |
| 8 | Gossypol(-), a potent small molecule inhibitor of Bcl-2/xl, improves response to radiation therapy and results in tumor regression of human prostate cancer | 1 |
| 9 | Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. | 180 |
| 10 | 4 | |
| 11 | 73 | |
| 12 | A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. | 83 |
| 13 | Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. | 56 |
| 14 | 20 | |
| 15 | Steroid receptors and the management of cancer | 15 |
| 16 | Clinical implications of glucocorticoid receptors in human leukemia. | 90 |
| 17 | An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. | 27 |
| 18 | Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture. | 115 |
| 19 | Re: M. Lippman, G. Bolan, and K. Huff. Three Papers on Hormones and Breast Cancer in Vitro. Cancer Res., 36: 4595–4601, 4602–4609, 4610–4618, 1976. | 1 |
| 20 | Insulin receptors in human breast cancer: relationship of binding, degradation and biological activity | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.